Work

Real-world outcomes of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) by race and ethnicity.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.7571

Authors: Frederick L. Locke, Tanya Siddiqi, Caron Alyce Jacobson, Armin Ghobadi, Sairah Ahmed, David Bernard Miklos, Miguel-Angel Perales, Javier Munoz, Brent Logan, Zhen-Huan Hu, Harry H. Miao, Kanwarjit Singh, Jina Shah, Hairong Xu, Marcelo C. Pasquini

Institutions: Moffitt Cancer Center, City Of Hope National Medical Center, Dana-Farber Cancer Institute, Washington University in St. Louis, The University of Texas MD Anderson Cancer Center, Stanford Medicine, Stanford University, Memorial Sloan Kettering Cancer Center, Mayo Clinic, Mayo Clinic in Arizona, Medical College of Wisconsin, Kite (United States)

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

OpenAlex ID: W4281889185

Cites:

Cited by: 18

Related to: 10